Maraninchi to be Marimbert's replacement at France's medicines regulator, Afssaps
This article was originally published in Scrip
Executive Summary
Dominique Maraninchi, currently head of France's national cancer institute (INC), is to head up the country's medicines regulator, Afssaps, a French government source, who wished to remain anonymous, told Scrip. Afssaps is to have two directors, although it is unclear who will join Professor Maraninchi at the helm.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.